[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals (AMPH) sees increased social volume and positive sentiment driven by potential undervaluation and pipeline developments. Analyst ratings show a PT of $XX from Barclays, suggesting potential upside.
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing generic and proprietary injectable, inhalation, and intranasal products.
Amphastar Pharmaceuticals, Inc. uses the ticker $AMPH for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Amphastar Pharmaceuticals, Inc. (AMPH) trading volume is up XXXXX% from the previous week.
- Amphastar Pharmaceuticals, Inc. (AMPH) sentiment is up XX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
AMPH is trading near a 52-week low, but recent positive news on earnings, product approvals, and pipeline development, coupled with mentions of buyback programs and analyst targets, suggest potential undervaluation and a slight increase in price over the last X days.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2024-12-13
1-Year Low: $XXXXX on 2025-07-19
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Amphastar Pharmaceuticals, Inc. (AMPH) is currently AltRank #1,756 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +210
X Month: XXXXX +82
X Months: XXXXX +4
X Year: XXXXX +1,229
1-Year High: XXXXX on 2025-08-06
1-Year Low: XX on 2025-01-01
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +2
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-09-23
Engagements: XX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXX +33%
X Months: XXXXXXX -XX%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2024-12-13
1-Year Low: XX on 2025-11-03
Engagements by network (24h): X: XX
Mentions: X (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XXX -X%
X Months: XXXXX +52%
X Year: XXXXX +166%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-30
Mentions by network (24h): X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Amphastar Pharmaceuticals, Inc. (AMPH) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +17%
X Months: XXXXX +181%
X Year: XXXXX +203%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-11
The most influential creators that mention Amphastar Pharmaceuticals, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BuyTheUgly | X | XX | X | XX |
Sentiment: X%
Sentiment 24-Hour Time-Series Raw Data
Current Value: X%
Daily Average: XX%
X Week: XX% +10%
X Month: XX% -XX%
X Months: XX% +15%
X Year: XX% -XX%
1-Year High: XXX% on 2025-02-12
1-Year Low: X% on 2025-01-26
Most Supportive Themes:
- Pipeline and ANDA Success: (30%) Amphastar Pharmaceuticals is developing new drugs and seeking approval for Abbreviated New Drug Applications (ANDAs), which could replace declining legacy revenues.
- Valuation and Undervaluation: (25%) Amphastar Pharmaceuticals is considered significantly undervalued with a GF Value of XXXXX and a GF Score of 74/100, indicating strong financial health.
- Shareholder Returns: (20%) The company may offer shareholder returns through buyback programs or improved free cash flow, with mentions of share repurchases.
Most Critical Themes:
- Legacy Revenue Decline: (15%) The company's legacy revenues are declining, necessitating the success of new pipeline drugs and ANDAs to offset this trend.
- Regulatory Settlements and Equity Raises: (10%) Amphastar Pharmaceuticals has settled with regulators for less than anticipated and has raised equity from related parties, which could impact financial performance.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
X Month: XXXXXX% -XXXXXX%
X Months: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
X Year: XXXXXX% -XXXXXX%
1-Year High: XXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-10-30
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-12-23
1-Year Low: XXXXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$5.30%
X Month: $XXXXXXXXXXXXX -$4.60%
X Months: $XXXXXXXXXXXXX -$2.20%
X Year: $XXXXXXXXXXXXX -$43%
1-Year High: $XXXXXXXXXXXXX on 2024-12-13
1-Year Low: $XXXXXXXXXXX on 2025-08-06
Top Amphastar Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Dont hesitate to load $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"
X Link @BuyTheUgly 2025-12-09T20:11Z XX followers, XXX engagements
"INITIATIONS 🔹 $AER Buy at Truist Secs; PT $XXX 🔹 $A Buy at Goldman; PT $XXX 🔹 $ALGN Equal Weight at Barclays; PT $XXX 🔹 $ALVO Underweight at Barclays; PT $X 🔹 $AS Overweight at Barclays; PT $XX 🔹 $AAL Market Perform at BMO; PT $XXXXX 🔹 $AMRX Overweight at Barclays; PT $XX 🔹 $AMPH Equal Weight at Barclays; PT $XX 🔹 $ANIP Overweight at Barclays; PT $XXX 🔹 $BRKR Sell at Goldman; PT $XX 🔹 $CAH Overweight at Barclays; PT $XXX 🔹 $COR Overweight at Barclays; PT $XXX 🔹 $COLL Overweight at Barclays; PT $XX 🔹 $DHR Buy at Goldman; PT $XXX 🔹 $DAL Outperform at BMO; PT $XX 🔹 $XRAY"
X Link @CHItraders 2025-12-09T12:21Z 5118 followers, XXX engagements
"Ready to roll $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"
X Link @BuyTheUgly 2025-12-08T15:58Z XX followers, XXX engagements
"$AMPH $AIPO Guys Don't miss the next move in a few hours. âž¡"
X Link @Stock_fither 2025-11-25T06:20Z XX followers, XX engagements